Sign in
4

Changes in Ownership

Cabaletta Bio, Inc. Filed Acc 0001193125-25-240356

Options or other derivatives

  • CHIEF COMMERCIAL OFFICER acquired 275,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gavel Steve · CHIEF COMMERCIAL OFFICER

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-13 Grant or award : show line 1 in the form Stock Option (Right to Buy) +275,000 275,000 D
Loading xslF345X05/ownership.xml…